Skip to content

The Effect of Scents Applied During Heel Blood Collection on Newborn Crying Duration, Pain, and Physiological Parameters

The Effect of Scents Applied During Heel Blood Collection on Newborn Crying Duration, Pain, and Physiological Parameters; A Randomized Controlled Study.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07350980
Acronym
Randomized
Enrollment
120
Registered
2026-01-20
Start date
2025-06-25
Completion date
2025-10-20
Last updated
2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal, Pain Management

Keywords

newborn

Brief summary

One of the most common and painful procedures in newborns is taking a capillary blood sample from the heel. This basic procedure, widely used in early health assessments, particularly in newborn screening tests, can cause mild to moderate pain.While both pharmacological and non-pharmacological approaches are used in pain management in newborns, the primary goal is to minimize and prevent painful stimuli as much as possible. Non-pharmacological methods are preferred in newborn care because they have no side effects, are easy to apply, low-cost, and caregiver-friendly.

Detailed description

This study was designed as a prospective, three-arm, parallel-group randomized controlled trial. It focused on non-pharmacological methods (lavender oil, mandarin oil, control group/standard care).Mothers of newborns meeting the recruitment criteria were informed of the study before heel prick testing and provided verbal and written consent. The standard approach involves performing heel prick testing on all newborns in their mothers' arms.

Interventions

OTHERoil

experiment

Sponsors

Sakarya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Intervention model description

2 intervention, 1 control

Eligibility

Sex/Gender
ALL
Age
37 Weeks to 42 Weeks
Healthy volunteers
Yes

Inclusion criteria

* Gestational age between 38-42 weeks, * APGAR score of 7 or higher at 5 minutes, * Neither mother nor baby should have used sedatives, tranquilizers, or anticonvulsants in the last 24 hours, * Heel prick blood should be planned as part of the routine neonatal screening program, * No blood should be taken from the heel prick for any other reason before the procedure, * Parents should voluntarily participate in the study.

Exclusion criteria

* Gestational age of 37 weeks or less, * APGAR score of 6 or lower at 5 minutes, * Having a diagnosed lung disease, * Having a history of atopic dermatitis, hypersensitivity, or allergies, * Parents should not wish to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
crying timesBefore the procedure, during the procedure, and for a total of 10 minutes after the procedure.measuring the crying duration with a stopwatch
heart rateBefore the procedure, during the procedure, and for a total of 10 minutes after the procedure.Measurement with pulse oximeter
Neonatal infant pain scaleBefore the procedure, during the procedure, and for a total of 10 minutes after the procedure.The scale includes f ive behavioral parameters (facial expression, crying, armmovements, leg movements, and state of arousal) and one physiological parameter (breathing patterns). Each behavior is scored 0-1; the crying parameter is scored 0-1-2. The lowest score is 0 and the highest score is 7.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026